bimagrumab plus semaglutide preserves lean mass and sustains fat loss during semaglutide-induced weight reduction in diet-induced obese mice Antibody blockade of activin type

Most common side effects were nausea and hypoglycaemia

Beyond diabetes care and weight loss, semaglutide has shown promise in promoting heart health

Availability of services may vary by state

Have a BMI of 27 or higher with weight-related health concerns Have tried diet and exercise without achieving lasting results Want a physician-supervised program with real lab testing Are interested in Semaglutide or Tirzepatide but want proper medical oversight Have insulin resistance, prediabetes, or metabolic syndrome Live in or near Atlanta and prefer in-person medical care Want a long-term plan, not just a prescription Your Care Team Led by Dr